-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

November 2005

The Effect of Switching on Compliance and Persistence: The Case of Statin Treatment

ByPatrick Thiebaud, PhD,Bimal V. Patel, PharmD,Michael B. Nichol, PhD,David M. Berenbeim, MD

November 1st 2005

Tailored Interventions to Introduce Influenza Vaccination

ByMary Patricia Nowalk, PhD, RD,Chyongchiou J. Lin, PhD,Richard Kent Zimmerman, MD, MPH,Judith A. Troy, MS,Alejandro Hoberman, MD,Diana H. Kearney, RN,Stephanie M. Cleary, BA

November 1st 2005

Continuity of Care and Cardiovascular Risk Factor Management: Does Care by a Single Clinician Add to Informational Continuity Provided by Electronic Medical Records?

ByDavid Litaker, MD, PhD,Cory Ritter, MD,Scott Ober, MD, MBA,David Aron, MD

November 1st 2005

Improving Adherence to Guidelines for Hypertension Drug Prescribing: Cluster-randomized Controlled Trial of General Versus Patient-specific Recommendations

ByMary K. Goldstein, MD,Philip Lavori, PhD,Robert Coleman, MS Pharm,Aneel Advani, MD,Brian B. Hoffman, MD

November 1st 2005

The Effects of Prescription Drug Cost Sharing: A Review of the Evidence

ByTeresa B. Gibson, PhD,Ronald J. Ozminkowski, PhD,Ron Z. Goetzel, PhD

November 1st 2005

Disease Management Produces Limited Quality-of-life Improvements in Patients With Congestive Heart Failure: Evidence From a Randomized Trial in Community-dwelling Patients

ByBrad Smith, PhD,Emma Forkner, MS,Barbara Zaslow, BSN,Richard A. Krasuski, MD,Karl Stajduhar, MD,Michael Kwan, MD,Robert Ellis, MD,Autumn Dawn Galbreath, MD,Gregory L. Freeman, MD

November 1st 2005

Trending on AJMC

COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

Real-World Data Show MASH Progresses Faster Than Trials Suggest

Sarcoma's Rarity Limits Trials and Biomarker-Driven Treatment Options: Alexander Spira, MD, PhD, FACP, FASCO

SYNC-T: Immunotherapy Platform Brings 4-Part Attack in Prostate Cancer, With More Trials Planned